BioCardia (BCDA) Short Interest Ratio & Short Volume $2.99 +0.04 (+1.36%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends BioCardia Short Interest DataCurrent Short Interest29,400 sharesPrevious Short Interest48,000 sharesChange Vs. Previous Month-38.75%Dollar Volume Sold Short$104,076.00Short Interest Ratio0.2 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares1,820,000 sharesFloat Size1,290,000 sharesShort Percent of Float2.28%Today's Trading Volume19,965 sharesAverage Trading Volume77,107 sharesToday's Volume Vs. Average26% Short Selling BioCardia ? Sign up to receive the latest short interest report for BioCardia and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBCDA Short Interest Over TimeBCDA Days to Cover Over TimeBCDA Percentage of Float Shorted Over Time Ad The Oxford ClubAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time to watch it.Watch Alex's "Next Magnificent Seven" presentation now. BioCardia Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202429,400 shares $104,076.00 -38.8%2.3%0.2 $3.54 6/30/202448,000 shares $142,560.00 -37.7%3.7%0.4 $2.97 6/15/202477,100 shares $262,911.00 +267.1%6.0%0.6 $3.41 5/31/202421,000 shares $97,020.00 -91.1%1.6%0.2 $4.62 5/15/2024235,400 shares $92,041.40 -10.4%N/A0.7 $0.39 4/30/2024262,800 shares $101,729.88 -3.1%N/A0.8 $0.39 Get the Latest News and Ratings for BCDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioCardia and its competitors with MarketBeat's FREE daily newsletter. 4/15/2024271,200 shares $100,994.88 -49.4%N/A0.8 $0.37 3/31/2024535,900 shares $218,111.30 -46.9%N/A1.4 $0.41 3/15/20241,010,000 shares $393,900.00 +927.5%6.2%2.7 $0.39 2/29/202498,300 shares $54,065.00 -67.0%0.7%0.3 $0.55 2/15/2024297,600 shares $127,968.00 +84.2%2.5%1 $0.43 1/31/2024161,600 shares $73,237.12 +22.8%1.3%0.1 $0.45 1/15/2024131,600 shares $85,329.44 -39.2%1.1%0 $0.65 12/31/2023216,600 shares $143,865.72 -31.8%1.8%0.1 $0.66 12/15/2023317,800 shares $190,997.80 -9.0%2.7%0.1 $0.60 11/30/2023349,100 shares $216,860.92 +132.0%3.5%0.1 $0.62 11/15/2023150,500 shares $142,222.50 +13.4%1.5%0.1 $0.95 10/31/2023132,700 shares $49,404.21 -35.2%1.3%1.2 $0.37 10/15/2023204,900 shares $90,156.00 +9.8%2.1%1.5 $0.44 9/30/2023186,600 shares $80,219.34 +48.1%1.6%1.4 $0.43 9/15/2023126,000 shares $49,770.00 -36.7%1.1%0.9 $0.40 8/31/2023199,000 shares $155,220.00 +8.0%1.7%1.8 $0.78 8/15/2023184,300 shares $162,147.14 +575.1%1.5%1.9 $0.88 7/31/202327,300 shares $28,119.00 -84.0%0.2%0.3 $1.03 7/15/2023171,000 shares $398,430.00 -14.2%1.4%2.4 $2.33 6/30/2023199,400 shares $532,398.00 -4.3%1.6%5.1 $2.67 6/15/2023208,300 shares $477,007.00 +3.8%1.6%5.6 $2.29 5/31/2023200,600 shares $355,062.00 +1,443.1%1.6%6.9 $1.77 5/15/202313,000 shares $24,050.00 -29.4%0.1%0.5 $1.85 4/30/202318,400 shares $37,904.00 -12.0%0.1%0.9 $2.06 4/15/202320,900 shares $40,964.00 -23.7%0.1%0.9 $1.96 3/31/202327,400 shares $53,430.00 -26.9%0.2%1 $1.95 3/15/202337,500 shares $73,875.00 +4.8%0.3%1.2 $1.97 2/28/202335,800 shares $78,760.00 +96.7%0.3%0.7 $2.20 2/15/202318,200 shares $40,586.00 -56.6%0.1%0.4 $2.23 1/31/202341,900 shares $106,426.00 -4.3%0.3%0.9 $2.54 1/15/202343,800 shares $100,302.00 -15.4%0.4%1 $2.29 12/30/202251,800 shares $108,262.00 -40.6%0.4%1.2 $2.09 12/15/202287,200 shares $149,112.00 +149.1%0.7%2 $1.71 11/30/202235,000 shares $64,750.00 +44.0%0.2%0.8 $1.85Man Who Called Nvidia at $1.10 Says Buy This Now... (Ad)In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.Watch Alex's "Next Magnificent Seven" presentation now. 11/15/202224,300 shares $45,684.00 -42.1%0.2%0.5 $1.88 10/31/202242,000 shares $81,900.00 -24.5%0.3%0.7 $1.95 10/15/202255,600 shares $116,204.00 -37.3%0.4%0.9 $2.09 9/30/202288,600 shares $171,884.00 -7.2%0.7%1.4 $1.94 9/15/202295,500 shares $193,865.00 -2.7%0.7%1.6 $2.03 8/31/202298,100 shares $195,219.00 +182.7%0.7%1.4 $1.99 8/15/202234,700 shares $58,296.00 -42.1%0.3%0.7 $1.68 7/31/202259,900 shares $86,855.00 -25.7%0.5%1.2 $1.45 7/15/202280,600 shares $124,930.00 -47.7%0.8%1.2 $1.55 6/30/2022154,200 shares $223,590.00 -29.3%1.6%0.2 $1.45 6/15/2022218,100 shares $307,521.00 -42.2%2.3%0.3 $1.41 5/31/2022377,300 shares $633,864.00 -2.8%2.9%0.6 $1.68 5/15/2022388,200 shares $543,480.00 -38.1%3.0%0.6 $1.40 4/30/2022627,000 shares $965,580.00 -49.8%5.0%0.7 $1.54 4/15/20221,250,000 shares $1.86 million +150.1%10.0%0.7 $1.49 3/31/2022499,900 shares $1.03 million -5.7%4.0%0.4 $2.07 3/15/2022530,100 shares $1.03 million -10.4%4.2%0.4 $1.95 2/28/2022591,700 shares $1.22 million -45.2%4.7%0.4 $2.07 2/15/20221,080,000 shares $2.39 million +425.3%8.5%0.8 $2.21 1/31/2022205,600 shares $380,360.00 -7.3%1.6%0.2 $1.85 1/15/2022221,700 shares $390,192.00 -13.8%1.7%1.5 $1.76 12/31/2021257,300 shares $499,162.00 +57.5%2.0%1.8 $1.94 12/15/2021163,400 shares $281,048.00 -30.9%1.3%1.2 $1.72 11/30/2021236,300 shares $484,415.00 -10.0%1.9%1.7 $2.05 11/15/2021262,600 shares $643,370.00 -10.5%2.1%1.9 $2.45 10/29/2021293,300 shares $821,240.00 +3.8%2.3%2.1 $2.80 10/15/2021282,700 shares $828,311.00 +8.7%2.2%2 $2.93 9/30/2021260,000 shares $816,400.00 +33.2%2.0%1.8 $3.14 9/15/2021195,200 shares $554,368.00 -0.9%1.5%1.4 $2.84 8/31/2021197,000 shares $581,150.00 -34.0%1.6%2.8 $2.95 8/13/2021298,300 shares $924,730.00 +5.3%2.3%4 $3.10 7/30/2021283,400 shares $940,888.00 -13.8%2.2%3.8 $3.32 7/15/2021328,900 shares $1.11 million -10.7%2.6%4.2 $3.36 6/30/2021368,200 shares $1.46 million +2.1%2.9%4.2 $3.97 6/15/2021360,500 shares $1.60 million -20.0%2.8%3.4 $4.43 5/28/2021450,400 shares $1.84 million +4.9%3.6%4.3 $4.09 5/14/2021429,300 shares $1.43 million +2.0%N/A3.6 $3.32 4/30/2021420,900 shares $1.49 million -0.2%N/A2.6 $3.54 4/15/2021421,900 shares $1.73 million -7.9%N/A1.8 $4.09 3/31/2021458,300 shares $1.82 million +68.4%N/A1.5 $3.98 3/15/2021272,200 shares $1.09 million +25.3%N/A0.5 $4.00 2/26/2021217,300 shares $873,546.00 +0.5%N/A0.1 $4.02 2/12/2021216,200 shares $1.08 million -63.5%N/A0.1 $4.98 1/29/2021591,600 shares $2.48 million -33.8%N/A0.2 $4.20 1/15/2021894,200 shares $3.35 million +49.8%N/A0.2 $3.75 12/31/2020597,100 shares $2.10 million +4,715.3%N/A0.2 $3.52 12/15/202012,400 shares $55,552.00 +9.7%N/A0 $4.48 11/30/202011,300 shares $26,555.00 -6.6%N/A0.2 $2.35 11/15/202012,100 shares $26,257.00 -57.4%N/A0.2 $2.17 10/30/202028,400 shares $58,220.00 +3.7%N/A0.3 $2.05Man Who Called Nvidia at $1.10 Says Buy This Now... (Ad)In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.Watch Alex's "Next Magnificent Seven" presentation now. 10/15/202027,400 shares $64,664.00 -9.9%N/A0.3 $2.36 9/30/202030,400 shares $69,008.00 +237.8%N/A0.3 $2.27 9/15/20209,000 shares $21,375.00 -61.9%N/A0 $2.38 BCDA Short Interest - Frequently Asked Questions What is BioCardia's current short interest? Short interest is the volume of BioCardia shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 29,400 shares of BCDA short. 2.28% of BioCardia's shares are currently sold short. Learn More on BioCardia's current short interest. Which institutional investors are shorting BioCardia? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioCardia: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for BioCardia? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.28% of BioCardia's floating shares are currently sold short. Is BioCardia's short interest increasing or decreasing? BioCardia saw a drop in short interest in the month of July. As of July 15th, there was short interest totaling 29,400 shares, a drop of 38.8% from the previous total of 48,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is BioCardia's float size? BioCardia currently has issued a total of 1,820,000 shares. Some of BioCardia's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioCardia currently has a public float of 1,290,000 shares. How does BioCardia's short interest compare to its competitors? 2.28% of BioCardia's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to BioCardia: JanOne Inc. (1.84%), Cara Therapeutics, Inc. (1.35%), VBI Vaccines Inc. (1.08%), PharmaCyte Biotech, Inc. (0.19%), Unicycive Therapeutics, Inc. (3.08%), Kiora Pharmaceuticals, Inc. (0.67%), Imunon, Inc. (2.99%), Cardio Diagnostics Holdings, Inc. (1.57%), RedHill Biopharma Ltd. (1.07%), PHAXIAM Therapeutics S.A. (0.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short BioCardia stock? Short selling BCDA is an investing strategy that aims to generate trading profit from BioCardia as its price is falling. BCDA shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioCardia? A short squeeze for BioCardia occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BCDA, which in turn drives the price of the stock up even further. How often is BioCardia's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCDA, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: JanOne Short Interest Cara Therapeutics Short Interest VBI Vaccines Short Interest PharmaCyte Biotech Short Interest Unicycive Therapeutics Short Interest Kiora Pharmaceuticals Short Interest Imunon Short Interest Cardio Diagnostics Short Interest RedHill Biopharma Short Interest PHAXIAM Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCDA) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCardia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCardia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
